AstraZeneca PLC is 40.1x more valuable than TG THERAPEUTICS, INC. by market capitalization ($286.27 B vs $7.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TGTX | AZN |
|---|---|---|
| Market cap | $7.14 B | $286.27 B |
| US-listed rank | #1140 | #45 |
| Revenue (latest FY) | $616.29M | - |
| Net income (latest FY) | $447.20M | - |
| Net margin | 72.6% | - |
| P/E (trailing FY) | 16.0 | - |
| SEC filings | 1,133 | 1,004 |
AstraZeneca PLC is 40.1x more valuable than TG THERAPEUTICS, INC. by market capitalization ($286.27 B vs $7.14 B).
Full pages: TG THERAPEUTICS, INC. and AstraZeneca PLC, or browse the full rankings.